Merck KGaA

MRK

Company Profile

  • Business description

    Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

  • Contact

    Frankfurter Strasse 250
    DarmstadtHE64293
    DEU

    T: +49 6151720

    E: [email protected]

    https://www.merckgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    62,461

Stocks News & Analysis

stocks

Undervalued ASX share retains wide moat rating despite regulatory pressures

Proposed price regulation impacts our fair value.
stocks

Our top ASX picks in every sector

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks

Tesla: Shares fall as deliveries come in below consensus

Long-term growth less reliant on auto sales.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,165.702.000.02%
CAC 408,223.93315.193.99%
DAX 4023,993.381,071.794.68%
Dow JONES (US)46,584.4685.42-0.18%
FTSE 10010,588.71239.922.32%
HKSE25,845.24728.712.90%
NASDAQ22,017.8521.510.10%
Nikkei 22556,308.422,878.865.39%
NZX 50 Index13,253.94184.281.41%
S&P 5006,616.855.020.08%
S&P/ASX 2008,951.8021.00-0.23%
SSE Composite Index3,995.00104.832.69%

Market Movers